Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Chien

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Digestive Diseases (Basel, Switzerland)|May 28, 2025
Projected Tumor Characteristics and Survival of Patients with Nonviral Hepatocellular Carcinoma in the USAJoanne Kimiko Liu, Nicholas Chien, Curtis Chong, et al.
Gut|August 9, 2024
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver diseaseXianhua Mao, Xinrong Zhang, Leslie Kam, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2025
Differential Characteristics and Survival Outcomes of Patients With Cirrhosis According to Underlying Liver AetiologyYu Shi, Nicholas Chien, Ashley Fong, et al.
Medcomm|April 8, 2026
Differential Mortality Risk by Age in Males and Females With Steatotic Liver DiseaseTaotao Yan, Nicholas Chien, Vy H Nguyen, et al.
The Lancet. Gastroenterology & Hepatology|May 16, 2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysisQing Ye, Biyao Zou, Yee Hui Yeo, et al.
Hepatology (Baltimore, Md.)|March 11, 2021
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine PracticeHidenori Toyoda, Jennifer Leong, Charles Landis, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2019
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysisJie Li, Biyao Zou, Yee Hui Yeo, et al.
Gastroenterology|October 21, 2018
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysisYee Hui Yeo, Hsiu J Ho, Hwai-I Yang, et al.
The American Journal of Gastroenterology|June 14, 2026
Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosisJiyoon Park, Sally Tran, Eiichi Ogawa, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Digestive Diseases (Basel, Switzerland)|May 28, 2025
Projected Tumor Characteristics and Survival of Patients with Nonviral Hepatocellular Carcinoma in the USAJoanne Kimiko Liu, Nicholas Chien, Curtis Chong, et al.
Gut|August 9, 2024
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver diseaseXianhua Mao, Xinrong Zhang, Leslie Kam, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2025
Differential Characteristics and Survival Outcomes of Patients With Cirrhosis According to Underlying Liver AetiologyYu Shi, Nicholas Chien, Ashley Fong, et al.
Medcomm|April 8, 2026
Differential Mortality Risk by Age in Males and Females With Steatotic Liver DiseaseTaotao Yan, Nicholas Chien, Vy H Nguyen, et al.
The Lancet. Gastroenterology & Hepatology|May 16, 2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysisQing Ye, Biyao Zou, Yee Hui Yeo, et al.
Hepatology (Baltimore, Md.)|March 11, 2021
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine PracticeHidenori Toyoda, Jennifer Leong, Charles Landis, et al.
The Lancet. Gastroenterology & Hepatology|March 24, 2019
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysisJie Li, Biyao Zou, Yee Hui Yeo, et al.
Gastroenterology|October 21, 2018
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysisYee Hui Yeo, Hsiu J Ho, Hwai-I Yang, et al.
The American Journal of Gastroenterology|June 14, 2026
Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosisJiyoon Park, Sally Tran, Eiichi Ogawa, et al.
Pageof 2